149394-66-1Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1.O.OFPKARFMSZDBYQF-ILKKLZGPSA-NCidofovir dihydrate is the dihydrate of the anhydrous form of cidofovir. A nucleoside analogue, it is an injectable antiviral used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. It has a role as an antineoplastic agent and an antiviral drug. It contains a member of cidofovir anhydrous.
149394-66-1DTXSID6041002CHEMBL5314375CHEBI:59495Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H301 (33.3%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P260, P264, P270, P280, P301+P316, P302+P352, P308+P316, P318, P321, P330, P332+P317, P362+P364, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
CIDOFOVIR DIHYDRATE
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]; DNA Polymerase Inhibitors [MoA]
VerwendenCidofovir Dihydrate is used in treatment of pain and combination with analgesics.
DefinitionChEBI: The dihydrate of the anhydrous form of cidofovir. A nucleoside analogue, it is an injectable antiviral used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…